Expressing support for the designation of July 2026 as “National Sarcoma Awareness Month”.

Expressing support for the designation of July 2026 as “National Sarcoma Awareness Month”.

Whereas sarcoma is a rare cancer of the bones or connective tissues, such as nerves, muscles, joints, fat, and blood vessels, that can arise nearly anywhere in the body;

Whereas, in the United States—

(1) about 18,000 individuals are diagnosed with sarcoma each year;

(2) approximately 7,600 individuals die from sarcoma each year; and

(3) over 236,000 individuals struggle with sarcoma at any given time;

Whereas, each year, about 1 percent of cancers diagnosed in adults and around 21 percent of cancers diagnosed in children are sarcoma;

Whereas more than 100 subtypes of sarcoma have been identified;

Whereas the potential causes of sarcoma are not well understood;

Whereas treatment for sarcoma can include surgery, radiation therapy, or chemotherapy;

Whereas sarcoma is often misdiagnosed and underreported; and

Whereas July 2026 would be an appropriate month to designate as National Sarcoma Awareness Month—

(1) to raise awareness about sarcoma; and

(2) to encourage more individuals in the United States to get properly diagnosed and treated: Now, therefore, be it

Resolved, That the Senate supports the designation of July 2026 as “National Sarcoma Awareness Month”.